SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (11879)11/21/2018 10:24:37 PM
From: Robohogs1 Recommendation

Recommended By
rkrw

   of 12215
 
Amzn faded hard but up a ton too. The late selling in broad mkt only hit bios modestly. Semis were up 50 bps after 2+% earlier. Bios had been leading a few rallies lately but fading faster too. I think the fading part is better tell personally. Long time coming.

I saw something in last few days on cnbc website saying to buy healthcare but no drugs because Ocare safe but drug pricing has a ton of noise. Specifically, buy hmos and hospitals. This is becoming so annoying. Hospitals and most service issues have worse pricing than bios/pharma but the bios get compared to gobal pricing and the rest do not. Fair point though is that bio pricing can be reigned in and they did have PharmaBoy and Epipen abuses. BUT the savings folks want just is not there when attacking 1 corner of health costs.

I think 2 reasons honestly. A lot of drugs not covered by insurance. Lots of holes exist. So 1, auite a few folks spending $100 a month on their phones and $200 on cable/internet do not want to pay $100 for a prescription. But 2) others truly cannot afford - just getting by. Hell neither probably can. Then add in chronically ill and cancer sufferers.

But the issue I think is we may need drug price restrictions to get to better stock trading.

Jon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext